The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction by Cohen, Christopher J. et al.
The coxsackievirus and adenovirus receptor is a
transmembrane component of the tight junction
Christopher J. Cohen*†, Joseph T. C. Shieh*, Raymond J. Pickles‡, Takatsugu Okegawa§, Jer-Tsong Hsieh§,
and Jeffrey M. Bergelson*
*Division of Immunologic and Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; ‡Cystic FibrosisPulmonary Research
and Treatment Center, University of North Carolina, Chapel Hill, NC 27599; and §Department of Urology, University of Texas
Southwestern Medical Center, Dallas, TX 75390
Edited by Lennart Philipson, Karolinska Institute, Stockholm, Sweden, and approved October 16, 2001 (received for review August 27, 2001)
The coxsackievirus and adenovirus receptor (CAR) mediates viral
attachment and infection, but its physiologic functions have not
been described. In nonpolarized cells, CAR localized to homotypic
intercellular contacts, mediated homotypic cell aggregation, and
recruited the tight junction protein ZO-1 to sites of cell–cell contact.
In polarized epithelial cells, CAR and ZO-1 colocalized to tight
junctions and could be coprecipitated from cell lysates. CAR ex-
pression led to reduced passage of macromolecules and ions across
cell monolayers, and soluble CAR inhibited the formation of func-
tional tight junctions. Virus entry into polarized epithelium re-
quired disruption of tight junctions. These results indicate that CAR
is a component of the tight junction and of the functional barrier
to paracellular solute movement. Sequestration of CAR in tight
junctions may limit virus infection across epithelial surfaces.
Group B coxsackieviruses and a number of adenovirus serotypesinitiate infection by binding to the coxsackievirus and adeno-
virus receptor (CAR) (1–3). CAR is a 46-kDa integral membrane
protein with a typical transmembrane region, a long cytoplasmic
domain, and an extracellular region composed of two Ig-like
domains (1, 2). Both adenovirus (4) and coxsackievirus (5) interact
with the N-terminal domain. Homologs of human CAR have been
characterized in mice (2, 6), rats, pigs, dogs (7), and zebrafish (8).
The murine and human proteins are very similar (91% amino acid
identity within the extracellular domain, 77% within the transmem-
brane domain, and 95% identity within the cytoplasmic domain).
Variant isoforms of CAR, which differ only at the C terminus and
which most likely result from alternative splicing, have been iden-
tified in mice (6), humans, and rats (7). Despite evidence of its
evolutionary conservation in mammals and nonmammalian verte-
brates, the function of CAR is not known.
Tight junctions are continuous circumferential intercellular con-
tacts at the apical poles of lateral cell membranes, appearing in
electron micrographs as a series of discrete contacts between the
plasma membranes of adjacent cells (9). Tight junctions form a
barrier that regulates the paracellular transit of water, solutes, and
immune cells across an epithelium (10), and are essential for
establishing cell polarity by separating the apical and basolateral
domains of polarized epithelial cells (11). ZO-1, the first tight
junction protein identified (12, 13), is an intracellular peripheral
membrane scaffolding protein important for tight junction struc-
ture and assembly. In the present study, we found that in polarized
epithelial cells CAR is expressed at the tight junction, where it
associates with ZO-1 and functions in the barrier to the movement
of macromolecules and ions.
Materials and Methods
Cell Culture. T-84, CALU-3, and 16HBE14o- cells were grown in
10% CO2 in a 1:1 mixture of DMEM and Ham’s F-12 medium with
10% FCS. To establish polarized monolayers, 5  105 cells per well
were plated on 12-mm diameter polyester filters with a pore size of
0.4 m (Transwell Clears, Corning-Costar, Cambridge, MA). Cells
were cultured for 1 week with medium changed every other day in
both the upper and lower chambers of the Transwell. Madin–Darby
canine kidney (MDCK) cells stably expressing human CAR (iso-
form 1 as originally reported in ref. 1) (MDCK-CAR) or trans-
fected with vector alone (MDCK-pcDNA) were grown in DMEM
with 10% FCS and 0.5 mg/ml G418 under 10% CO290% air as
described (14). Chinese hamster ovary (CHO) cells stably trans-
fected with cDNA constructs encoding human CAR (1) (CHO-
CAR cells), CAR linked to a glycosylphosphatidylinositol (GPI)
anchor (GPI-CAR), or transfected with vector alone (CHO-
pcDNA) were cultured in nucleoside-free -MEM  10% dialyzed
FCS as described (15).
Human well-differentiated tracheobronchial epithelial cells
derived from airway specimens were obtained and cultured as
described (16). Briefly, 3  105 human airway cells were plated
onto Transwell-col inserts (diameter, 24 mm; pore size 0.4 m)
and confluent monolayers were maintained with an air–liquid
interface (medium in the lower chamber only) for 30 days.
Immunofluorescence Microscopy. For CAR staining, CHO cells were
grown on glass coverslips for 2 days and fixed in 1% paraformal-
dehyde in PBS for 30 min at room temperature. Cells were
incubated in 10% goat serum and 0.2% Triton X-100 in PBS with
a polyclonal anti-CAR rabbit antibody that had been raised against
recombinant CAR extracellular domain and purified by affinity to
the extracellular domain immobilized on N-hydroxysuccinimide-
Sepharose. After washing with PBS, cells were incubated with
FITC-conjugated goat antibody to rabbit Ig (Sigma) in PBS with
10% goat serum and 0.2% Triton X-100. Specificity of the antibody
was confirmed by Western blot and immunofluorescence of CAR-
expressing and mock-transfected CHO cells (data not shown). For
ZO-1 staining, fixed CHO cells were exposed to polyclonal rabbit
anti-ZO-1 antibody (Zymed) in PBS with 10% goat serum and
0.2% Triton X-100 followed by a FITC-conjugated secondary
antibody. Cells were examined with a Nikon Eclipse 800 fluores-
cence microscope.
For localization of CAR and ZO-1 in human well-
differentiated airway epithelium, monolayers were fixed in 4%
paraformaldehyde in PBS for 30 min. Cells were stained with
affinity-purified rabbit anti-CAR antibody and mouse monoclo-
nal anti-ZO-1 antibody (Zymed) in PBS with 10% goat serum
and 0.2% Triton X-100 for 4 h. Cells were washed and exposed
to Cy-3-conjugated goat anti-rabbit Ig and FITC-conjugated
goat anti-mouse Ig for 2 h. Cells were examined with a Leica TCS
4D confocal microscope. Human airway epithelium showed no
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staining with the control monoclonal antibody MOPC 195 or
with preimmune rabbit serum.
Confluent monolayers of T-84, CALU-3, or 16HBE14o- cells
were fixed in 1% paraformaldehyde for 30 min and stained with
affinity-purified rabbit anti-CAR antibody and mouse monoclo-
nal anti-ZO-1 antibody (Zymed) for 3–4 h in PBS with 10% goat
serum and 0.2% Triton X-100 followed by FITC-conjugated goat
anti-mouse Ig and Cy-3-conjugated goat anti-rabbit Ig (Jackson
ImmunoResearch Laboratories). Cells were examined by con-
focal microscopy. T-84 cells showed no staining with preimmune
rabbit serum or the control monoclonal antibody MOPC 195.
There was no bleed-through of fluorescence from either the
FITC channel into the Cy-3 channel or the Cy-3 channel into the
FITC channel when cells were stained only for CAR or ZO-1.
There was no cross-species reactivity seen for the antirabbit or
the antimouse secondary antibodies. For detection of endoge-
nous CAR in MDCK cells, cells were fixed in cold methanol,
rather than paraformaldehyde, and stained as above; no immu-
noreactivity with the affinity-purified rabbit anti-CAR antibody
was detected in paraformaldehyde-fixed MDCK cells.
Electron Microscopy. Polarized monolayers of T-84 cells were fixed
in 4% paraformaldehyde and 0.2% glutaraldehyde in 100 mM
sodium cacodylate buffer (pH 7.4) with 1 mM CaCl2 for 3 h at 4°C.
The monolayers were dehydrated by using a graded series of
ethanol concentrations and infiltrated in LR white. After section-
ing, specimens were blocked in 10 mM sodium phosphate with 0.9%
sodium chloride with 1% ovalbumin  0.2% cold water fish skin
gelatin for 1 h. Grids were incubated overnight at 4°C with rabbit
polyclonal anti-CAR and mouse monoclonal anti-ZO-1 antibody.
After washing, the grids were incubated for 1 h at room temperature
with 8-nm gold-labeled anti-mouse antibody to detect ZO-1 and
18-nm gold-labeled anti-rabbit antibody to detect CAR. Grids were
counterstained with 2% uranyl acetate and examined with a
JEOL–JEM 1010 electron microscope. No staining was evident
with preimmune rabbit serum or the control antibody MOPC 195.
There was no cross-species reactivity seen for the gold-labeled
anti-rabbit or anti-mouse secondary antibodies.
Immunoprecipitation. Confluent monolayers of T-84 cells were
washed twice with PBS and removed from the tissue culture flask
with a cell scraper. Cells were lysed for 30 min at 4°C in PBS with
0.5% Triton X-100 and 0.02% SDS with 1 mM DTT, 2 mM PMSF,
and 0.15 trypsin inhibitory units (TIU)/ml aprotinin. Insoluble
material was pelleted at high speed in a microcentrifuge for 15 min
in the cold. The supernatant was precleared for 1 h with protein G
beads. The supernatant was incubated overnight at 4°C with the
anti-CAR monoclonal antibody RmcB covalently linked to protein
G beads, with a rabbit anti-ZO-1 antibody (Zymed), or with the
control monoclonal antibody MOPC 195 linked to protein G beads.
The beads were washed on ice with PBS containing 0.5% Triton
X-100, then boiled for 5 min in 30 l Laemmli sample buffer. Beads
were separated by brief centrifugation, and supernatant was run on
an SDS7.5% polyacrylamide gel and transferred to a poly(vinyli-
dene difluoride) (PVDF) membrane. The membrane was blocked
overnight in PBS with 10% milk and probed with mouse anti-ZO-1
antibody (Zymed) or rabbit anti-CAR antiserum followed by
horseradish peroxidase-conjugated antibody to rabbit or mouse Ig
(Amersham Pharmacia) in PBS with milk, then developed with
ECL reagents (Amersham Pharmacia), and exposed to film.
FITC-Dextran Flux. Confluent monolayers of CHO-CAR or mock-
transfected CHO cells were grown on transwell membranes and
FITC-dextran (1 mg/ml; average molecular weight 38,200) was
added to the upper chamber. After 2 h, aliquots were collected
from the lower chamber and assayed by fluorimetry (excitation
wavelength set at 492 nm and emission at 520 nm).
Transepithelial Resistance (TER) Measurement. Confluent monolay-
ers of mock-transfected (MDCK-pcDNA) or CAR-expressing
MDCK cells (14) were grown on Transwell membranes at
confluency for 5 days. The TER was measured with an epithelial
voltohmmeter (World Precision Instruments, Sarasota, FL).
Inhibition of Tight Junction Formation with Soluble CAR. To disrupt
tight junctions, monolayers of T-84 cells grown on Transwell filters
were exposed to 2.5 mM EDTA in PBS for 30 min at 37°C. This
disruption resulted in a decrease in the TER of the monolayers
from 4,767  398 cm2 to 190  29 cm2. EDTA was replaced
with medium alone, medium containing 5 g of the hCAR extra-
cellular domain produced as an Ig–Fc fusion protein (soluble CAR)
(17), or medium containing 5 g of the avian sarcoma virus
Fig. 1. CAR in transfected cells. (A and B) CAR is localized at homotypic cell
junctions in CAR-expressing CHO cells. (A) CHO cells stably transfected with
CAR were stained with anti-CAR antibody and examined by immunofluores-
cence microscopy. CAR staining is enhanced at sites of intercellular contact. (B)
Mock-transfected (CAR-negative) and CAR-transfected CHO cells were plated
together on coverslips and then stained for CAR 48 h later. CAR is concentrated
at contacts between CAR-positive cells (arrowheads), but not at contacts
between CAR-positive and CAR-negative cells (filled arrows). (C and D) CAR
mediates aggregation of CAR-transfected CHO cells. Clustering of CAR-
transfected (C) and mock-transfected (D) CHO cells viewed by light micros-
copy. (E and F) CAR-mediated aggregation is caused by homophilic interac-
tions. CHO-CAR cells labeled with DiI (red) and mock-transfected CHO cells
labeled with DiO (green) were mixed in equal numbers then incubated
together for 5 h. (E, 200; F, 600.) (G and H) CAR-expressing and mock-
transfected CHO cells were stained for ZO-1. (G) Mock-transfected CHO cells
show diffuse cytoplasmic staining of ZO-1. (H) ZO-1 localized at intercellular
contacts between CHO-CAR cells.
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envelope protein produced as an Fc fusion protein [ASVenv Fc
(control protein)]. The TER was measured as an indication of tight
junction reassembly.
Cell Adhesion Assay. Cells were trypsinized into a single cell
suspension at a concentration of 1  106 cells per ml and mixed
gently at room temperature for 5 h. The number of aggregated
cells (2 cells contacting each other) was determined by using
a hemacytometer. In some experiments, CHO-CAR cells la-
beled with 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocya-
nine (DiI; 20 g/ml) and CHO-pcDNA cells labeled with
3,3-dioctadecyloxacarbocyanine (DiO; 40 g/ml) were mixed in
equal numbers, incubated together for 5 h, and examined by
fluorescence microscopy.
Infection of Polarized Monolayers with Coxsackievirus and Adenovi-
rus. Confluent monolayers of T-84 cells were exposed to 10
plaque-forming units per cell of coxsackievirus B3-Nancy (CBV3),
which initiates infection by binding to CAR and not the alternative
receptor decay accelerating factor (18), or adenovirus type 5
encoding green fluorescent protein (AdGFP) from either the apical
or basolateral surface. Basolateral infection was performed by
inverting transwell inserts and applying virus to the basolateral
surface. For coxsackievirus infection, cells were exposed to virus for
1 h, washed, and incubated for 16 h at 37°C. Cells were fixed with
a 50:50 methanolacetone mix, stained for virus with a CBV3
mouse monoclonal antibody (Chemicon) followed by FITC-
conjugated goat anti-mouse Ig, and examined by immunofluores-
cence microscopy. Staining for viral antigens was specific, as
Fig. 2. Association between
CAR and ZO-1 in epithelial cells.
(A and B) CAR and ZO-1 colocal-
ize when examined by confocal
microscopy. (A) Human well-dif-
ferentiated tracheobronchial ep-
ithelial cells were stained with
anti-CAR polyclonal rabbit serum
and Cy3-conjugated secondary
antibody (red) or with monoclo-
nal anti-ZO-1 antibody and FITC-
conjugated secondary antibody
(green). (B)PolarizedT-84colonic
epithelial cells were examined as
in A. (C) Colocalization of CAR
and ZO-1 by immunoelectron mi-
croscopy. T-84 cell monolayers
were fixed and stained with rab-
bit polyclonal anti-CAR and
mouse monoclonal anti-ZO-1 an-
tibody, then with 8-nm gold-
labeled anti-mouse Ig to detect
ZO-1 and 18-nm gold-labeled an-
ti-rabbit Ig antibodies to detect
CAR. Cells were examined by
electron microscopy as described
in Materials and Methods. (D and
E) CAR and ZO-1 coprecipitate.
T-84 cell lysates were immuno-
precipitated with anti-ZO-1 anti-
body (D lane 1 and E lane 2), anti-
CARantibody(D lane2andE lane
1), or with a control antibody (D
and E lane 3). Immunoprecipi-
tates were electrophoresed in
SDSpolyacrylamide gels, trans-
ferred to a poly(vinylidene diflu-
oride) membrane, and probed
with a monoclonal anti-ZO-1 an-
tibody (D) or anti-CAR antiserum
(E) as described in Materials and
Methods. Arrowheads mark the
location of ZO-1 (D) and CAR (E),
which immunoprecipitates as a
doublet (22).











determined by absence of staining in noninfected cells, and absence
of staining with a control antibody. For adenovirus infection,
monolayers were exposed to virus for 2 h, washed, incubated for
48 h at 37°C, and examined for GFP expression by fluorescence
microscopy. In some experiments, tight junctions were disrupted
with EDTA before infection as described above. To determine
whether CBV3 or AdGFP infection of T-84 cells was CAR-
dependent, monolayers were incubated with a 1:100 dilution of
anti-CAR serum or preimmune serum for 1 h after tight junctions
were disrupted with EDTA and before infection by CBV3 or
AdGFP.
Results
CAR Is Concentrated at Homotypic Cell–Cell Contacts. In CHO-CAR
cells, CAR was highly concentrated at sites of cell–cell contact (Fig.
1A). Localization was seen only when CAR was present on both
opposing cell membranes and not where CHO-CAR cells came into
contact with mock-transfected cells (Fig. 1B). CAR linked to the
cell membrane by means of a GPI anchor (GPI-CAR), and thus
lacking cytoplasmic and transmembrane domains, also concen-
trated at sites of cell–cell contact in CHO cells (data not shown);
this suggests that CAR localization to intercellular contacts was
driven by homotypic interactions between the extracellular domains
of CAR molecules on opposing cell membranes.
CAR Mediates Homotypic Cell Adhesion. When incubated with
gentle agitation, CHO-CAR cells formed large aggregates (Fig.
1C), whereas CHO-pcDNA cells remained primarily as single
cells (Fig. 1D). Similar results were obtained with CAR-
transfected murine L cells (data not shown). In separate exper-
iments, 68  6% of CHO-CAR cells formed aggregates after 5 h
as compared with 14  7% of mock-transfected cells. When
CHO-CAR cells labeled with fluorescent DiI (red) were mixed
with DiO labeled CHO-pcDNA cells (green), the CAR-
expressing cells formed large aggregates that did not incorporate
the mock-transfectants (Fig. 1 E and F). These results demon-
strate that CAR-mediated aggregation resulted from homophilic
interactions. While these studies were in progress, Honda et al.
(19) demonstrated that murine CAR can mediate homophilic
aggregation of C6 rat glioma cells.
CAR Recruits ZO-1 to Cell–Cell Contacts in CHO Cells. ZO-1 was
expressed diffusely throughout the cytoplasm of CHO-pcDNA cells
(Fig. 1G). In contrast, in CHO-CAR cells, ZO-1 localized to sites
of cell–cell contact (Fig. 1H), suggesting that ZO-1 associates with
CAR and that CAR recruits ZO-1 to intercellular junctions in CHO
cells. CHO-CAR cells and mock-transfected CHO cells expressed
similar amounts of ZO-1 as determined by Western blotting of cell
lysates (data not shown). In transfected CHO cells lacking the
complete cytoplasmic domain (35), ZO-1 staining was diffuse and
not concentrated at intercellular junctions, indicating that ZO-1
localization to cell–cell contacts depended on interactions with the
CAR cytoplasmic domain (data not shown).
CAR and ZO-1 Associate in Epithelial Cell Tight Junctions. ZO-1 is
localized to tight junctions of mature epithelial cells. We stained
primary human tracheobronchial airway cells for CAR and ZO-1
after the cells had been cultured on semipermeable Transwell
filters for 1 month—conditions that result in the formation of a
well-differentiated epithelial monolayer. CAR and ZO-1 colo-
calized at the apical pole of the lateral cell membrane (Fig. 2A),
indicating that CAR, like ZO-1, is concentrated in tight junc-
tions. Similar colocalization of endogenous CAR and ZO-1 was
seen in the human colonic cell line T-84 (Fig. 2B), in the human
airway epithelial cell lines CALU-3 and 16HBE14o- (not
shown), and in MDCK cells (not shown).
Immunoelectron microscopy, which has been the definitive
technique for localizing proteins to specialized cell junctions,
demonstrated that CAR and ZO-1 localized together at the
apical junction of T-84 cells in structures with morphologic
characteristics of tight junctions (Fig. 2C). Although occasional
CAR and ZO-1 molecules were seen at other locations, both
molecules were heavily concentrated at tight junctions.
To determine whether there was a physical association between
CAR and ZO-1, we immunoprecipitated endogenous CAR from
detergent lysates of T-84 cells, then immunoblotted the precipitates
with a monoclonal anti-ZO-1 antibody (Fig. 2D). ZO-1 was pre-
cipitated by the anti-CAR monoclonal antibody RmcB and by the
anti-ZO-1 antibody. In a reciprocal experiment, we immunopre-
cipitated endogenous ZO-1 from T-84 cells and immunoblotted the
precipitates with anti-CAR antiserum (Fig. 2E). CAR was precip-
itated by anti-ZO-1 antibody as well as by RmcB. Neither ZO-1 nor
CAR was precipitated by control antibodies. Taken together, these
results indicate that CAR and ZO-1 associate with each other,
either through a direct interaction or through an interaction in-
volving one or more other junctional proteins.
CAR Expression Limits Paracellular Solute Flow. The tight junction
functions as a barrier to movement of both large molecules and
ions. We measured the passage of a macromolecule, FITC-
Fig. 3. CAR is a barrier to paracellular solute and ion movement. (A) FITC
dextran flux was measured across CHO cell monolayers. Confluent monolayers
of CHO-CAR and mock-transfected CHO cells were grown on transwell mem-
branes. FITC-labeled dextran was added to the upper chamber and after 2 h,
aliquots of fluid from the lower chamber were collected and assayed by
fluorimetry. Graph shows mean and standard deviation for triplicate mono-
layers. Results are representative of three experiments. (B) TER of MDCK cell
monolayers. Confluent monolayers of mock-transfected (MDCK-pcDNA) or
CAR-expressing MDCK cells were grown on Transwell membranes at conflu-
ency for 5 days. TER was measured with an epithelial voltohmmeter. Graph
shows mean and standard deviation for quadruplicate monolayers. Results are
representative of three experiments. (C) Soluble CAR inhibits the formation of
tight junctions. Monolayers of T-84 cells were exposed to EDTA to disrupt tight
junctions. EDTA was replaced with medium alone, medium containing 5 g of
soluble CAR, or medium containing 5 g of the avian sarcoma virus envelope
protein [ASVenv Fc (control protein)]. The TER was measured as an indication
of tight junction reassembly. Graph shows mean and standard deviation for
triplicate monolayers. Results are representative of three experiments.
15194  www.pnas.orgcgidoi10.1073pnas.261452898 Cohen et al.
dextran, across CHO cell monolayers grown on Transwell mem-
branes. Significantly less dextran crossed monolayers of CHO-
CAR cells than crossed CHO-pcDNA cell monolayers (Fig. 3A).
The transepithelial resistance—a measure of ion flux—across
polarized monolayers of MDCK cells transfected with human
CAR was significantly greater than that measured across mono-
layers of mock-transfected MDCK cells (Fig. 3B). We used
EDTA to disrupt the junctions between T-84 cells, then permit-
ted tight junctions to regenerate in medium alone or in the
presence of excess recombinant CAR extracellular domain (Fig.
3C). Electrical resistance of monolayers exposed to control
protein did not differ from that of untreated monolayers. In
contrast, transepithelial resistance was significantly reduced in
monolayers exposed to soluble CAR. All these results demon-
strate a role for CAR in junctional barrier function.
Virus Infection Is Limited by CAR Localization. To determine whether
virus could infect T-84 cells when CAR was localized to tight
junctions, polarized monolayers were exposed, from either the
apical or basolateral side, to coxsackievirus B3 or to adenovirus
type 5 encoding GFP. Under either condition, cells were rarely
infected with either virus, as determined by expression of
coxsackievirus protein or expression of GFP (Fig. 4). Disruption
of tight junctions with EDTA resulted in a significant increase in
infection of epithelial cells. Infection after EDTA treatment was
inhibited by polyclonal anti-CAR antiserum but not by preim-
mune serum. In control experiments, EDTA treatment of CHO
cell monolayers grown on Transwell filters did not alter their
susceptibility to infection (not shown). These results indicate that
CAR sequestered within tight junctions is inaccessible to cox-
sackievirus and adenovirus, and that disruption of junctions
facilitates infection by permitting virus to interact with CAR.
Discussion
We and others have previously observed that CAR is absent from
the apical surface of polarized epithelial cells (16, 20–22). In the
experiments reported here we found that CAR is localized to the
tight junction itself, where it associates, directly or indirectly, with
the junctional scaffolding protein ZO-1.
A number of proteins are found at tight junctions. Most of them,
like ZO-1, are peripheral membrane proteins associated with the
cytoplasmic face of the junctional membrane (10). Only three
tight-junction proteins are known to span the membrane. Occludin
(23) and the claudin family of junction proteins (24, 25) have
multiple membrane-spanning domains, whereas junctional adhe-
sion molecule, a member of the Ig superfamily, has a single
membrane-spanning domain (26). Based on the observations re-
ported here, CAR is the fourth integral membrane component of
the tight junction to be identified, and the second with a single
transmembrane domain.
Because the transmembrane components of the tight junction
extend into the paracellular space, they are likely to be important
for junctional barrier function, whereas cytoplasmic peripheral
membrane components may serve in assembly and regulation of
junctions, tethering to intracellular structures, and transmission
of signals. Occludin (27), claudins (28), and junctional adhesion
Fig. 4. CAR-mediated coxsackievirus and adenovirus infection of polarized T-84 cells requires disruption of tight junctions. Confluent monolayers of T-84 cells
were exposed to coxsackievirus B3 or to adenovirus 5 encoding GFP from either the apical or basolateral surface. Cells were examined for coxsackievirus protein
expression 16 h later or for GFP expression 48 h later. In some experiments, tight junctions were disrupted with EDTA before monolayers were exposed to virus.
In some experiments, monolayers were incubated with rabbit anti-CAR antiserum or with preimmune rabbit serum after EDTA treatment.











molecule (26, 29) all have adhesive properties, which may
contribute to a paracellular seal that prevents movement of
solutes. We found that CAR promoted cell adhesion and re-
stricted the movement of both solutes and ions between trans-
fected cells. It is thus likely that CAR contributes to the barrier
function of tight junctions.
In an earlier study, CAR was seen to be expressed diffusely on
the basolateral membrane of cultured airway epithelial cells (16),
rather than concentrated specifically at tight junctions. However,
consistent with our present findings, we more recently observed that
CAR was concentrated at the apex of the basolateral membrane of
airway cells in culture and in tracheobronchial tissue specimens
(14). This variation may reflect differences in the origin of the
airway cells, in culture conditions, or in degree of maturation. A
subpopulation of junctional adhesion molecule is present on the
lateral membrane as well as in tight junctions of some polarized cells
(30), and similar observations have been reported for occludin (31).
In nonpolarized cells, CAR may be expressed at other cell contacts.
We have observed that in cardiac myocytes, CAR colocalized with
N-cadherin at intercalated discs (data not shown), a site where
ZO-1 is also expressed (32).
The redistribution of ZO-1 in CAR-transfected cells and the
coprecipitation of ZO-1 and CAR from cell lysates indicate that
CAR associates with the tight-junction protein ZO-1. The CAR
cytoplasmic domain contains potential recognition sites for
protein–protein interaction domains: the C-terminal motif SIV
may interact with PDZ domains, which recognize the C-terminal
motif [(ST)-X-(hydrophobic amino acid) (33)]; the peptide
PTLPP resembles the SH3 domain recognition motif PXXPX
(34). CAR’s association with ZO-1 may depend on interactions
with ZO-1’s PDZ or SH3 domains. The CAR C terminus
contains multiple serine, threonine, and tyrosine residues that
may be sites of phosphorylation; phosphorylation regulates
association of other integral membrane proteins with the tight
junction (31). We found that CAR expression led to relocaliza-
tion of ZO-1 in a nonpolarized cell; the association between
CAR and ZO-1 may affect the subcellular localization of these
proteins in polarized cells as well.
The CAR N-terminal Ig-like domain forms homodimers both in
crystals and in solution (8); this dimerization may be responsible for
CAR accumulation at cell–cell contacts as well as for CAR-
mediated cell adhesion. We found that human CAR promoted
homotypic cell aggregation, consistent with results recently re-
ported for murine CAR (19). However, it is not certain that CAR’s
primary function involves adhesion per se as opposed to intercellular
recognition. We recently observed that CAR expression leads to
modulation of the cell cycle regulatory proteins p21 and Rb and
inhibits the growth of bladder carcinoma cells, effects that are
prevented by antibody that recognizes the CAR extracellular
domain (35). Homotypic CAR interactions may thus initiate signals
contributing to contact-dependent inhibition of cell growth.
A deficiency of viral receptors on the epithelial cell surface is
recognized as a barrier to adenovirus infection from the apical side
(16, 20, 21), and we now find that sequestration of CAR in tight
junctions can be a barrier to adenovirus infection from the baso-
lateral surface as well. In addition, localization of CAR in the tight
junction is an impediment to coxsackievirus infection. Junctional
adhesion molecule, another transmembrane component of the tight
junction, was recently identified as a receptor for mammalian
reoviruses (36). It thus appears that three unrelated viruses—all of
which must traverse respiratory or gastrointestinal epithelium in the
course of infection—have evolved to interact with receptors that
may be inaccessible from the epithelial surface. Infection by these
pathogens in vivo may require loss of epithelial integrity, transport
across M cells of the intestine (37), or interactions with alternative
receptors present on the apical surface.
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